FDA Advisory Committee votes ‘No’ on MAPS/Lykos MDMA-assisted therapy approval

แชร์
ฝัง
  • เผยแพร่เมื่อ 16 ธ.ค. 2024

ความคิดเห็น • 5

  • @byronchurch
    @byronchurch 5 หลายเดือนก่อน +1

    I am very optimistic about the use of mdma for dealing with trauma as there are so many of us that can be helped . It’s understandable how one could be read as culty or evangelical . It boggles the mind to think this could be held up !

  • @nathanmeyer1826
    @nathanmeyer1826 5 หลายเดือนก่อน +1

    Does Health Canada follow US-FDA with regards of health safety or make their own decisions? I thought Numinus was a Canadian company that operates in both contries.. would health canada approve MDMA-PT with Lykos’s data?

    • @Sprint2023
      @Sprint2023 5 หลายเดือนก่อน

      Health Canada said they will be following FDA decision closely

    • @nathanmeyer1826
      @nathanmeyer1826 5 หลายเดือนก่อน

      @@Sprint2023is that because of aliance agreements? I would think Canada would be its own sovereignty with its people and health. For example, nobody gave Australia the go to approve MDMA and psilocybin.

    • @Sprint2023
      @Sprint2023 5 หลายเดือนก่อน

      @@nathanmeyer1826 Health Canada is monitoring the FDA review "with interest", they have not yet received an application for market authorization of MDMA. If Lykos applied for approval in Canada I'd imagine they would have better odds of getting market access. But the US is a much bigger market so they want to get access their first to be able to use US revenues to fund global expansion.